Filing Details

Accession Number:
0000950170-25-030330
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-03 06:01:08
Reporting Period:
2025-02-27
Filing Date:
2025-03-03
Accepted Time:
2025-03-03 06:01:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886744 Geron Corp GERN Pharmaceutical Preparations (2834) 752287752
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1987259 Alan Scott Samuels C/O Geron Corporation
919 E Hillsdale Blvd. Suite 250
Foster City CA 94404
Evp, Chief Legal Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-02-27 15,000 $1.61 26,682 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reported transaction represents the open market purchase of 15,000 shares at an executed price of $1.61 per share.
  2. The number of securities reported reflects the open market purchase of 15,000 shares and acquisition on June 30, 2024 of 7,432 shares and on December 31, 2024 of 4,250 shares of Geron common stock pursuant to the Employee Stock.